The TBE vaccine is recommended for individuals who live in or travel to areas where TBE is endemic. This includes certain regions of Europe (e.g., parts of Austria, Germany, and Switzerland) and Asia. It's particularly advised for people who are at higher risk due to activities in tick-prone areas, such as hiking or camping.

The TBE vaccine is highly effective, providing robust protection against the virus. After completing the recommended vaccination schedule, the majority of individuals develop strong immunity that significantly reduces the risk of contracting tick-borne encephalitis.

The primary vaccination course for TBE typically involves three doses: the first and second doses are given 1 to 3 months apart, and the third dose is administered 5 to 12 months after the second dose. A booster dose is recommended every 3 to 5 years, depending on the risk level and guidelines.

Common side effects of the TBE vaccine are usually mild and may include pain or redness at the injection site, low-grade fever, or fatigue. Serious side effects are rare. If you experience severe reactions or symptoms beyond what is mentioned, consult a healthcare professional.

Yes, the TBE vaccine has been proven to be safe through extensive clinical trials and real-world use. It is approved by health authorities and recommended for use in areas where TBE is a concern.

For detailed information, you can refer to the Green Book published by the UK Department of Health, which provides comprehensive guidelines on vaccination. Additionally, your healthcare provider can offer personalized advice based on your travel plans and health status.